Gaines Kristin Sallee has filed 26 insider transactions across 1 company since February 2023.
Most recent transaction: a option exercise of 43181 shares of NATIONAL HEALTH INVESTORS INC ($NHI) on February 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2026 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | M | Common Stock | 43181 | $82.12 | 73,763.0000 | 47,638,502 | 36.92% | 0.09% |
| Feb. 1, 2026 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | M | Common Stock | 18334 | $53.41 | 116,944.0000 | 47,638,502 | 18.59% | 0.04% |
| Feb. 1, 2026 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | M | Common Stock | 18333 | $53.41 | 98,610.0000 | 47,638,502 | 22.84% | 0.04% |
| Feb. 1, 2026 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | M | Common Stock | 18333 | $53.41 | 80,277.0000 | 47,638,502 | 29.60% | 0.04% |
| Feb. 1, 2026 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | M | Stock Option (Right to buy) 2022 | 18334 | $0.00 | 0.0000 | 47,638,502 | 100.00% | 0.04% |
| Feb. 1, 2026 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | M | Stock Option (Right to buy) 2022 | 18333 | $0.00 | 0.0000 | 47,638,502 | 100.00% | 0.04% |
| Feb. 1, 2026 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | M | Stock Option (Right to buy) 2022 | 18333 | $0.00 | 0.0000 | 47,638,502 | 100.00% | 0.04% |
| March 3, 2025 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | A | Common Stock | 4000 | $0.00 | 61,944.0000 | 45,687,942 | 6.90% | 0.01% |
| March 3, 2025 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | A | Stock Option (Right to Buy) 2025 | 8333 | $0.00 | 8,333.0000 | 45,687,942 | 9999.99% | 0.02% |
| March 3, 2025 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | A | Stock Option (Right to Buy) 2025 | 8333 | $0.00 | 8,333.0000 | 45,687,942 | 9999.99% | 0.02% |
| March 3, 2025 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | A | Stock Option (Right to Buy) 2025 | 8334 | $0.00 | 8,334.0000 | 45,687,942 | 9999.99% | 0.02% |
| Sept. 25, 2024 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | F | Common Stock | 48665 | $84.66 | 57,944.0000 | 43,442,849 | 45.65% | 0.11% |
| Sept. 25, 2024 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | M | Stock Options (Right to Buy) 2-25-2021 | 18334 | $0.00 | 0.0000 | 43,442,849 | 100.00% | 0.04% |
| Sept. 25, 2024 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | M | Stock Options (Right to Buy) 2-25-2021 | 18333 | $0.00 | 0.0000 | 43,442,849 | 100.00% | 0.04% |
| Sept. 25, 2024 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | M | Stock Options (Right to Buy) 2-25-2021 | 18333 | $0.00 | 0.0000 | 43,442,849 | 100.00% | 0.04% |
| Sept. 25, 2024 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | M | Common Stock | 18333 | $69.20 | 69,942.0000 | 43,442,849 | 35.52% | 0.04% |
| Sept. 25, 2024 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | M | Common Stock | 18333 | $69.20 | 88,275.0000 | 43,442,849 | 26.21% | 0.04% |
| Sept. 25, 2024 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | M | Common Stock | 18334 | $69.20 | 106,609.0000 | 43,442,849 | 20.77% | 0.04% |
| Feb. 23, 2024 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | A | Common Stock | 3000 | $0.00 | 51,609.0000 | 43,409,841 | 6.17% | 0.01% |
| Feb. 23, 2024 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | A | Stock Option (Right to Buy) 2024 | 8333 | $0.00 | 8,333.0000 | 43,409,841 | 9999.99% | 0.02% |
| Feb. 23, 2024 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | A | Stock Option (Right to Buy) 2024 | 8333 | $0.00 | 8,333.0000 | 43,409,841 | 9999.99% | 0.02% |
| Feb. 23, 2024 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | A | Stock Option (Right to Buy) 2024 | 8334 | $0.00 | 8,334.0000 | 43,409,841 | 9999.99% | 0.02% |
| May 5, 2023 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | SVP/Chief Transaction Officer | A | Common Stock | 4000 | $0.00 | 48,609.0000 | 43,388,742 | 8.97% | 0.01% |
| Feb. 24, 2023 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | Chief Credit Officer | A | Stock Option (Right to Buy) 2023 | 8334 | $0.00 | 8,334.0000 | 43,388,742 | 9999.99% | 0.02% |
| Feb. 24, 2023 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | Chief Credit Officer | A | Stock Option (Right to Buy) 2023 | 8333 | $0.00 | 8,333.0000 | 43,388,742 | 9999.99% | 0.02% |
| Feb. 24, 2023 | NATIONAL HEALTH INVESTORS INC | $NHI | Gaines Kristin Sallee | Chief Credit Officer | A | Stock Option (Right to Buy) 2023 | 8333 | $0.00 | 8,333.0000 | 43,388,742 | 9999.99% | 0.02% |